Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype

被引:28
作者
Su, Linjuan [1 ]
Huang, Hailong [1 ]
An, Gang [1 ]
Cai, Meiying [1 ]
Wu, Xiaoqing [1 ]
Li, Ying [1 ]
Xie, Xiaorui [1 ]
Lin, Yuan [1 ]
Wang, Meiying [1 ]
Xu, Liangpu [1 ]
机构
[1] Fujian Med Univ, Fujian Prov Matern & Childrens Hosp, Fujian Prov Key Lab Prenatal Diag & Birth Defect, Affiliated Hosp, Fuzhou, Fujian, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2019年 / 7卷 / 08期
关键词
chromosomal microarray analysis; karyotyping; nuchal translucency; prenatal diagnosis; GENOMIC MICROARRAY; THICKNESS; MOSAICISM; DELETIONS; 22Q11.2;
D O I
10.1002/mgg3.811
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT >= 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5 mm in China) and the recommended cutoff value for CMA (NT of 3.5 mm) whether should be excluded from CMA test. Methods Singleton pregnant women (N = 192) who had undergone invasive procedures owing to an increased NT (NT >= 2.5 mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations. Results Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5-3.4 mm, and 55 fetuses with NT >= 3.5 mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT >= 3.5 mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences in the incidence of all CNVs and clinically significant CNVs in the two groups (p > 0.05). Conclusion CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5-3.4 mm and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Increased nuchal translucency in children with congenital heart defects and normal karyotype-is there a correlation with mortality?
    Kristensen, Rasmus
    Omann, Camilla
    Gaynor, J. William
    Rode, Line
    Ekelund, Charlotte K.
    Hjortdal, Vibeke E.
    [J]. FRONTIERS IN PEDIATRICS, 2023, 11
  • [42] Is there any relationship between adverse pregnancy outcome and first trimester nuchal translucency measurements in normal karyotype fetuses?
    Uysal, Fatma
    Cosar, Emine
    Yucesoy, Kaya
    Gencer, Meryem
    Cevizci, Sibel
    Gungor, Aysenur
    Hacivelioglu, Servet
    Uysal, Ahmet
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (05) : 531 - 534
  • [43] Contribution of chromosomal microarray analysis and next-generation sequencing to genetic diagnosis in fetuses with normal karyotype
    Akalin, Munip
    Demirci, Oya
    Dizdarogullari, Gizem E.
    Ciftci, Erman
    Karaman, Ali
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (02) : 519 - 529
  • [44] Neurodevelopmental outcome at 2 years of corrected age in fetuses with increased nuchal translucency thickness and normal karyotype compared with matched controls
    Buffin, R.
    Fichez, A.
    Decullier, E.
    Roux, A.
    Bin, S.
    Combourieu, D.
    Pastor-Diez, B.
    Huissoud, C.
    Picaud, J. -C.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 57 (05) : 790 - 797
  • [45] Prenatal Diagnosis of Fetuses With Increased Nuchal Translucency by Genome Sequencing Analysis
    Choy, Kwong Wai
    Wang, Huilin
    Shi, Mengmeng
    Chen, Jingsi
    Yang, Zhenjun
    Zhang, Rui
    Yan, Huanchen
    Wang, Yanfang
    Chen, Shaoyun
    Chau, Matthew Hoi Kin
    Cao, Ye
    Chan, Olivia Y. M.
    Kwok, Yvonne K.
    Zhu, Yuanfang
    Chen, Min
    Leung, Tak Yeung
    Dong, Zirui
    [J]. FRONTIERS IN GENETICS, 2019, 10
  • [46] Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5mm
    Zhang, Zhu
    Hu, Ting
    Wang, Jiamin
    Li, Qinqin
    Wang, He
    Liu, Shanling
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [47] Abnormal cardiac function in fetuses with increased nuchal translucency
    Rizzo, G
    Muscatello, A
    Angelini, E
    Capponi, A
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 21 (06) : 539 - 542
  • [48] Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses
    von Kaisenberg, CS
    Brand-Saberi, B
    Jonat, W
    Nicolaides, KH
    [J]. PRENATAL AND NEONATAL MEDICINE, 1999, 4 (06): : 431 - 440
  • [49] Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses
    von Kaisenberg, CS
    Nicolaides, KH
    Jonat, W
    Brand-Saberi, B
    [J]. GYNAKOLOGE, 1999, 32 (03): : 193 - 199
  • [50] Chromosomal abnormalities and structural defects in fetuses with increased nuchal translucency at a Chinese tertiary medical center
    Zhang, Huijing
    Wang, Shuang
    Feng, Chunli
    Zhao, Hongyan
    Zhang, Weiwei
    Sun, Yu
    Yang, Huixia
    [J]. FRONTIERS IN MEDICINE, 2023, 10